Trial Outcomes & Findings for Dosing Music for Anxiety Reduction in Parturients (NCT NCT05966766)
NCT ID: NCT05966766
Last Updated: 2025-05-30
Results Overview
Verbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention. A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible. Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.
COMPLETED
NA
40 participants
4-8 minutes
2025-05-30
Participant Flow
Participant milestones
| Measure |
Mozart
Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
|
Patient Preference
Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.
|
|---|---|---|
|
Overall Study
STARTED
|
20
|
20
|
|
Overall Study
COMPLETED
|
20
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Dosing Music for Anxiety Reduction in Parturients
Baseline characteristics by cohort
| Measure |
Mozart
n=20 Participants
Subjects in this arm listened to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
|
Patient Preference
n=20 Participants
Subjects in this arm listened to music from a list of pre-selected pieces of their own choosing.
|
Total
n=40 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
32.7 Years
STANDARD_DEVIATION 5.4 • n=5 Participants
|
33.5 Years
STANDARD_DEVIATION 4.9 • n=7 Participants
|
33.0 Years
STANDARD_DEVIATION 5.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
20 Participants
n=5 Participants
|
20 Participants
n=7 Participants
|
40 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
4 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
16 Participants
n=5 Participants
|
16 Participants
n=7 Participants
|
32 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
8 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=5 Participants
|
12 Participants
n=7 Participants
|
22 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Gestational age
|
38.6 Weeks
STANDARD_DEVIATION 0.8 • n=5 Participants
|
38.6 Weeks
STANDARD_DEVIATION 0.9 • n=7 Participants
|
38.6 Weeks
STANDARD_DEVIATION 0.9 • n=5 Participants
|
|
Gravidity
|
2.4 Pregnancies
STANDARD_DEVIATION 1 • n=5 Participants
|
3.6 Pregnancies
STANDARD_DEVIATION 1.3 • n=7 Participants
|
3 Pregnancies
STANDARD_DEVIATION 2.2 • n=5 Participants
|
|
Parity
|
1.1 Births
STANDARD_DEVIATION 0.8 • n=5 Participants
|
1.3 Births
STANDARD_DEVIATION 1.4 • n=7 Participants
|
1.2 Births
STANDARD_DEVIATION 1.1 • n=5 Participants
|
PRIMARY outcome
Timeframe: 4-8 minutesVerbally rated anxiety on numeric rating scale (NRS) of 0-10, before and after intervention. A rating of 0 meant the patient had no anxiety, while a rating of 10 meant the patient had the worst anxiety possible. Must have been at least a 1-point decrease between pre- and post-intervention scores to be considered a positive response, larger decrease meant a better outcome.
Outcome measures
| Measure |
Mozart
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
|
Patient Preference
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.
|
|---|---|---|
|
Anxiety Score
Before
|
5.9 score on a scale
Standard Deviation 2.6
|
6.1 score on a scale
Standard Deviation 2.3
|
|
Anxiety Score
After
|
3.6 score on a scale
Standard Deviation 2.3
|
3.1 score on a scale
Standard Deviation 2.4
|
SECONDARY outcome
Timeframe: 4-8 minutes6-question abbreviated state-trait anxiety inventory (STAI) questions asked and scored on a 6-24 point scale (higher is more anxiety) for before and after intervention. Decrease in score after intervention was considered a positive response, with larger decreases indicating better responses.
Outcome measures
| Measure |
Mozart
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces by Mozart that have been previously shown to have beneficial effects on anxiety.
|
Patient Preference
n=20 Participants
Subjects in this arm will listen to music from a list of pre-selected pieces of their own choosing.
|
|---|---|---|
|
STAI
Before
|
12.7 score on a scale
Standard Deviation 4.3
|
14.4 score on a scale
Standard Deviation 4.1
|
|
STAI
After
|
10.3 score on a scale
Standard Deviation 3.2
|
10.8 score on a scale
Standard Deviation 3.2
|
Adverse Events
Mozart
Patient Preference
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place